Global Cold Blister Packaging Effective Choice Pharmaceutical Market

Cold Blister Packaging Effective Choice Pharmaceutical Market Size, Share, Growth Analysis, By Material (Aluminum, Oriented-polyamide), By Application (Pharmaceuticals, Electronics and Semiconductors), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35I2252 | Region: Global | Published Date: February, 2025
Pages: 219 |Tables: 61 |Figures: 75

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Cold Blister Packaging Effective Choice Pharmaceutical Market size was valued at USD 3.98 Billion in 2024 and is poised to grow from USD 4.28 Billion in 2025 to USD 7.63 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026–2033). 

    The global cold blister packaging effective choice pharmaceutical market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Amcor Plc (Switzerland) ', 'Klöckner Pentaplast (Germany) ', 'Südpack (Germany) ', 'TekniPlex (USA) ', 'Constantia Flexibles (Austria) ', 'CCL Industries Inc. (Canada) ', 'UFlex Limited (India) ', 'Nelipak Healthcare Packaging (USA) ', 'Sonoco Products Company (USA) ', 'WestRock Company (USA) ', 'Honeywell International Inc. (USA) ', 'ACG Group (India) ', 'Gerresheimer AG (Germany) ', 'AptarGroup, Inc. (USA) ', 'West Pharmaceutical Services, Inc. (USA) ', 'WINPAK LTD. (Canada) ', 'SteriPack Group (Ireland) ', 'Blisterpak, Inc. (USA) ', 'Berry Global Group, Inc. (USA) ', 'Schott AG (Germany) '

    The main factor driving market expansion is the rise in the use of blister packaging for tablets and capsules. blister packaging is extensively employed in tablets and capsules. Individual capsules are frequently kept in a bigger carton using blister packing, which shields the contents from contamination. The most common material structure utilized to produce blister packs all around the world is the OPA/Al/PVC multilayer structure. Additionally, blister packs can shield materials from environmental influences including contamination and humidity for prolonged periods. Thus due to its convenient usage it has driven the cold blister packaging effective choice pharmaceutical industry significantly.

    The expansion of the generic market, escalation of financial investment in the pharmaceutical, marketing products through e-commerce, and fast rising drug delivery industry are further predicted to enhance the market growth. The market dynamics have been altered by oral ingestible containers, inhalers, nasal sprays, and other comparable items, which are expected to encourage the expansion of pharmaceutical packaging. The demand for packaging is rising as a result of rising customer demands for convenience and better sealing characteristics, increased demand for a variety of products, and enhanced environmental norms.

    The Asia Pacific region dominated the cold blister packaging effective choice pharmaceutical industry in 2021. China had the highest revenue share—more than 30.0%. The country's access to raw materials like PVC and aluminium is assisting the market's expansion. According to a report from the Government of Canada, the China had  produced 36 million tonnes in 2019, followed by India, Russia, and Canada,   The value of the market is being driven by the presence of significant players in the area, including Shanghai Haishun New Pharmaceutical Packaging Ltd. and Ningbo Dragon Packaging Technology Co., Ltd. Market Dynamics. Further, the increasing prevalence of contract manufacturing across growing countries like China and India is contributing to the market growth in the country. India is anticipated to expand at the fastest rate IN the forecasting year. This is because of rising investments in the region's healthcare sector and government support for the growth and progress of the pharmaceutical industry in the country. Another important element promoting the development of the market in the nation is the rising prevalence of chronic disorders among the populace.

    Related Reports

    Cold Form Blister Packaging Market
    Buy Now GET FREE SAMPLE
    Blister Packaging Market
    Buy Now GET FREE SAMPLE
    Pharmaceutical Packaging Market
    Buy Now GET FREE SAMPLE
    Pharmaceutical Processing and Packaging Equipment Market
    Buy Now GET FREE SAMPLE
    Antimicrobial Packaging Market
    Buy Now GET FREE SAMPLE
    Temperature Controlled Packaging Solutions Market
    Buy Now GET FREE SAMPLE
    Cold Chain Packaging Market
    Buy Now GET FREE SAMPLE
    Passive Temperature Controlled Packaging Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Cold Blister Packaging Effective Choice Pharmaceutical Market

    Report ID: SQMIG35I2252

    $5,300
    BUY NOW